MarketPulse

equity raise

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Diamond Equity Research

MAIA Biotech Raises $30M, Eyes 2026 Milestones with Ateganosine Trial Data

MAIA Biotech secures $30M funding and FDA Fast Track designation for ateganosine cancer therapy, with Phase 2 data showing 17.8-month median survival.
MAIAclinical developmentPhase 3 trial
Investing.comInvesting.com··Timothy Fries

Intuitive Machines Stock Slides 16% Despite $175M Funding Round

Intuitive Machines stock fell 16% despite announcing $175M funding round, as investors worried about shareholder dilution despite capital gains for growth initiatives.
LUNRspace infrastructurestock selloff